middle.news
Why Is Alterity Therapeutics’ Share Price Surging Ahead of Clinical Data?
9:31am on Monday 14th of July, 2025 AEST
•
Healthcare
Read Story
Why Is Alterity Therapeutics’ Share Price Surging Ahead of Clinical Data?
9:31am on Monday 14th of July, 2025 AEST
Key Points
No undisclosed material information explaining recent share price rise
Upcoming mid-year Phase 2 ATH-201 and ATH-202 clinical data releases
Scheduled investor meetings and non-deal roadshow in late July
Company confirms compliance with ASX continuous disclosure rules
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Alterity Therapeutics (ASX:ATH)
OPEN ARTICLE